Order Article Reprints

Erber R, Kailayangiri S, Huebner H, Ruebner M, Hartmann A, Häberle L, Meyer J, Völkl S, Mackensen A, Landgraf L, et al. Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes. Cancers. 2021; 13(21):5577. https://doi.org/10.3390/cancers13215577

Erber, Ramona, Sareetha Kailayangiri, Hanna Huebner, Matthias Ruebner, Arndt Hartmann, Lothar Häberle, Julia Meyer, Simon Völkl, Andreas Mackensen, Laura Landgraf, and et al. 2021. "Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes" Cancers 13, no. 21: 5577. https://doi.org/10.3390/cancers13215577

Erber, R., Kailayangiri, S., Huebner, H., Ruebner, M., Hartmann, A., Häberle, L., Meyer, J., Völkl, S., Mackensen, A., Landgraf, L., Geppert, C. I., Schulz-Wendtland, R., Beckmann, M. W., Fasching, P. A., Farwick, N., Rossig, C., & Gass, P. (2021). Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes. Cancers, 13(21), 5577. https://doi.org/10.3390/cancers13215577